News
NADMED Selected for US Market Entry Program in Collaboration with Mayo Clinic
NADMED has been selected to join the prestigious AMPlify program, a U.S. market entry initiative...
Affinity Joins NADMED Network in London
Affinity Biomarker Labs, based in London, UK, is the latest partner to join the NADMED network,...
NADMED Positioned Among Fastest-Growing Clinical Laboratory Tests
Research and Markets, one of the world’s leading market research firms, has identified NADMED as...
NADMED Secures €3.5M to Accelerate International Sales Expansion
The investment round was led by Finnish science-based startup investor Nordic Science Investments...
Research Calls for Controlled Dosing of NAD-boosters
A study involving a healthy population of 1162 individuals revealed that persistent high niacin...
High NAD amounts slow growth of proliferative cancer cells
In a recent study, researchers found that high NAD(H)+ amounts slow down the growth of highly...